Request a Regulatory Services Proposal Prefix Ms. Mr. Dr. Name * First Name Last Name Email * Phone Number * Company * Title Stage/Phase of Development * Clinical Development through NDA NDA through Pre-Approval Phase 1 Phase 2 Phase 3 Phase 4 Post-marketing Regulatory Compliance Aspect(s) – Choose all that Apply Audit Bioanalysis Biomarkers Case Study Report (CSR) Chemistry Manufacturing Controls (CMC) Clinical Laboratory Improvement Amendments (CLIA) Companion Diagnostic (CDx) Corrective Action-Preventive Action (CAPA) electronic Case Report Form (eCRF) European Medicines Agency (EMA) Food and Drug Administration (FDA) Good Documentation Practice (GDP) Good Laboratory Practice (GLP) Good Manufacturing Practice (GMP) Good Pharmacovigilance Practice (GVP) Informed Consent Form (ICF) Inspection Inspectional Observations - Form 483 Investigational Device Exempt (IDE) Investigational New Drug (IND) Investigator's Brochure (IB) Japanese Pharmaceuticals and Medical Devices Agency (PMDA) Multinational Medical Device Single Audit Program (MDSAP) New Drug Application (NDA) Premarket Approval (PMA) Quality Management System (QMS) Significant Risk Determination (SRD) Standard Operating Procedure (SOP) Training Trial Master File (TMF) Vialing and Labeling Warning Letter Additional Details